Background: It has been suggested, on a few GSD1b patients, that vitamin E improves neutrophil count and reduces frequency and severity of infections.
The main objective of the present study was to investigate the efficacy of vitamin E on the neutropenia, neutrophil dysfunction and IBD in the entire Italian caseload of GSD1b patients.
Patients and methods: Eighteen GSD1b patients, median age at the time of the study protocol 14.5 (range, 0.6–42 years), were enrolled from four Italian referral centres for metabolic diseases. For the evaluation of the efficacy of vitamin E, neutrophil count and function, frequency of infections needing hospitalization and inflammatory bowel activity were evaluated periodically all over one year before and during vitamin E therapy.
Results: Frequency (1.5 ± 0.1 vs. 6.0 ± 0.6, p = 0.003) and severity of infections (2.2 ± 0.2 vs. 3.7 ± 0.4, p = 0.003) were lower and mean value of neutrophil count (1,583 ± 668 vs. 941 ± 809, p = 0.03) higher during vitamin E supplementation. Neutrophil function results improved during vitamin supplementation. PCDAI showed a significant reduction in the inflammatory activity during vitamin E supplementation (9 ± 1.4 vs. 13 ± 1.2, p = 0.006). In seven patients G-CSF requirement decreased and the dose was reduced after the end of the study.
In conclusion, our study demonstrated the efficacy of vitamin E supplementation. Vitamin E has evident advantages as compared to G-CSF, as it can be assumed orally, and it has not been associated with severe side effects.
Antioxidant IBD Infection severity score Neutropenia Neutrophil dysfunction Vitamin E
This is a preview of subscription content, log in to check access.
The study was partially supported by the Italian Agency of Drugs (AIFA). Study protocol n. FARM5S3JT5
Kim SY, Nguyen AD, Gao JL, Murphy PM, Mansfield BC, Chou JY (2006) Bone marrow-derived cells require a functional glucose-6-phosphate transporter for normal myeloid functions. J Biol Chem 281:28794–28801CrossRefPubMedGoogle Scholar
Kim SY, Jun HS, Mead PA, Mansfield BC, Chou JY (2008) Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type 1b. Blood 111:5704–5711CrossRefPubMedPubMedCentralGoogle Scholar
Kuijpers TW, Maianski NA, Tool AT, Smit GP, Rake JP, Roos D, Visser G (2003) Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 101:5021–5024CrossRefPubMedGoogle Scholar
Kulkarni SS, Cary LH, Gambles K, Hauer-Jensen M, Kumar KS, Ghosh SP (2012) Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor. Int Immunopharmacol 14:495–503Google Scholar
Leuzzi R, Bánhegyi G, Kardon T, Marcolongo P, Capecchi PL, Burger HJ, Benedetti A, Fulceri R (2003) Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b. Blood 101:2381–2387CrossRefPubMedGoogle Scholar
Melis D, Parenti G, Della Casa R, Sibilio M, Berni Canani R, Terrin G, Cucchiara S, Andria G (2003) Crohn’s-like ileo-colitis in patients affected by glycogen storage disease Ib: two years’ follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr 92:1415–1421CrossRefPubMedGoogle Scholar
Melis D, Fulceri R, Parenti G, Marcolongo P, Gatti R, Parini R, Riva E, Della Casa R, Zammarchi E, Andria G, Benedetti A (2005) Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature. Eur J Pediatr 164:501–508CrossRefPubMedGoogle Scholar
Melis D, Della Casa R, Parini R, Rigoldi M, Cacciapuoti C, Marcolongo P, Benedetti A, Gaudieri V, Andria G, Parenti G (2009) Vitamin E supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b. Eur J Pediatr 168:1069–1074CrossRefPubMedGoogle Scholar
Pinsk M, Burzynski J, Yhap M, Fraser RB, Cummings B, Ste-Marie M (2002) Acute myelogenous leukemia and glycogen storage disease 1b. J Pediatr Hematol Oncol 24:756–758CrossRefPubMedGoogle Scholar
Seidner DL, Lashner BA, Brzezinski A, Banks PL, Goldblum J, Fiocchi C, Katz J, Lichtenstein GR, Anton PA, Kam LY, Garleb KA, Demichele SJ (2005) An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 3:358–369Google Scholar
Singh VK, Brown DS, Kao TC (2009) Tocopherol succinate: a promising radiation countermeasure. Int Immunopharmacol 9:1423–1430CrossRefPubMedGoogle Scholar
Ventura MT, Serlenga E, Tortorella C, Antonaci S (1994) In vitro vitamin E and selenium supplementation improves neutrophil-mediated functions and monocyte chemoattractant protein-1 production in the elderly. Cytobios 77:225–232Google Scholar
Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, Ullrich K, Smit GP (2000) Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr 137:187–191CrossRefPubMedGoogle Scholar
Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, Wendel U, Smit GP (2002) European Study on Glycogen Storage Disease Type I. Consensus guidelines for management of glycogen storage disease type 1b -European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 161(Suppl 1):S120–S123Google Scholar
Visser G, de Jager W, Verhagen LP, Smit GP, Wijburg FA, Prakken BJ, Coffer PJ, Buitenhuis M (2012) Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients. J Inherit Metab Dis 35:287–300CrossRefPubMedGoogle Scholar